Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170349 · ClinicalTrials.gov registry record · NA
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT03170349 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 124 participants.
The verdict
NCT03170349, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, performance and clinical outcomes of the Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
Interventions
- DEVICE Mitral Valve Repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170349
The ClinicalTrials.gov registry entry for NCT03170349 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mitral Valve Repair is the first listed.
NCT03170349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03170349 about?
NCT03170349 is a clinical study titled "The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study". The purpose of this study is to assess the safety, performance and clinical outcomes of the Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
What is the current status of trial NCT03170349?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2017-06-27. Estimated completion is 2025-05-27.
What interventions are being tested in trial NCT03170349?
The interventions under investigation include: Mitral Valve Repair (DEVICE).
Who is sponsoring clinical trial NCT03170349?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.